1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RXFP3 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BOLA2 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA APOBEC3B CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AC243756.1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA SRP19 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA HMGA1 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GPRC5D CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GAREM1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA DCUN1D2 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA RNF44 CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV